Drug patents in South Korea are handled by the Korean Intellectual Property Office (KIPO). Patents provide exclusive rights for up to 20 years from the filing date. Patent linkage ensures that generic drugs cannot be approved until the original drug’s patent expires, promoting innovation while protecting intellectual property rights.